Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 1
2016 3
2017 1
2018 4
2019 7
2020 12
2021 12
2022 11
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced uveitis: A review.
Agarwal M, Dutta Majumder P, Babu K, Konana VK, Goyal M, Touhami S, Stanescu-Segall D, Bodaghi B. Agarwal M, et al. Among authors: touhami s. Indian J Ophthalmol. 2020 Sep;68(9):1799-1807. doi: 10.4103/ijo.IJO_816_20. Indian J Ophthalmol. 2020. PMID: 32823396 Free PMC article. Review.
Biotherapies in Uveitis.
Leclercq M, Desbois AC, Domont F, Maalouf G, Touhami S, Cacoub P, Bodaghi B, Saadoun D. Leclercq M, et al. Among authors: touhami s. J Clin Med. 2020 Nov 8;9(11):3599. doi: 10.3390/jcm9113599. J Clin Med. 2020. PMID: 33171664 Free PMC article. Review.
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.
Leclercq M, Andrillon A, Maalouf G, Sève P, Bielefeld P, Gueudry J, Sené T, Moulinet T, Rouvière B, Sène D, Desbois AC, Domont F, Touhami S, El Chamieh C, Cacoub P, Bodaghi B, Biard L, Saadoun D. Leclercq M, et al. Among authors: touhami s. Ophthalmology. 2022 May;129(5):520-529. doi: 10.1016/j.ophtha.2021.11.013. Epub 2021 Nov 16. Ophthalmology. 2022. PMID: 34793830 Free article.
Sight Threat, Life Threat.
Dentel A, Touhami S, Bodaghi B. Dentel A, et al. Among authors: touhami s. Ophthalmol Retina. 2023 Dec;7(12):1122. doi: 10.1016/j.oret.2023.07.011. Epub 2023 Aug 3. Ophthalmol Retina. 2023. PMID: 37542499 No abstract available.
Choroidal Nodules in Ocular Sarcoidosis.
Abramowicz S, Wassef M, Touhami S. Abramowicz S, et al. Among authors: touhami s. Sarcoidosis Vasc Diffuse Lung Dis. 2023 Dec 20;40(4):e2023039. doi: 10.36141/svdld.v40i4.15122. Sarcoidosis Vasc Diffuse Lung Dis. 2023. PMID: 38126497 Free PMC article.
Perspectives for immunotherapy in noninfectious immune mediated uveitis.
Touhami S, Gueudry J, Leclercq M, Touitou V, Ghembaza A, Errera MH, Saadoun D, Bodaghi B. Touhami S, et al. Expert Rev Clin Immunol. 2021 Sep;17(9):977-989. doi: 10.1080/1744666X.2021.1956313. Epub 2021 Jul 26. Expert Rev Clin Immunol. 2021. PMID: 34264142 Review.
Current practice in the management of ocular toxoplasmosis.
Yogeswaran K, Furtado JM, Bodaghi B, Matthews JM; International Ocular Toxoplasmosis Study Group; Smith JR. Yogeswaran K, et al. Br J Ophthalmol. 2023 Jul;107(7):973-979. doi: 10.1136/bjophthalmol-2022-321091. Epub 2022 Feb 23. Br J Ophthalmol. 2023. PMID: 35197262
Eplerenone for chronic central serous chorioretinopathy.
Stanescu-Segall D, Touhami S, Bodaghi B, LeHoang P. Stanescu-Segall D, et al. Among authors: touhami s. Lancet. 2020 Nov 14;396(10262):1556-1557. doi: 10.1016/S0140-6736(20)32327-8. Lancet. 2020. PMID: 33189169 No abstract available.
56 results